Cluster A (Odd/Eccentric): Paranoid, Schizoid (prefers solitude), Schizotypal (magical thinking). Cluster B (Dramatic): Antisocial, Borderline (DBT #1!), Histrionic, Narcissistic. Cluster C (Anxious): Avoidant, Dependent, OCPD.
Obsessive-Compulsive Personality Disorder (OCPD): EGO-SYNTONIC lifelong perfectionism, rigidity, orderliness (patient thinks traits are rational). OCD: EGO-DYSTONIC intrusive obsessions & time-consuming compulsions -> SSRI + ERP.
Anorexia: BMI <18.5, lanugo, osteoporosis, amenorrhea, euthyroid sick. Bulimia: BMI >=18.5, parotid enlargement, enamel erosion, Russell sign, hypochloremic hypokalemic alkalosis -> CBT + Fluoxetine (Bupropion CONTRAINDICATED!).
Rapid carbohydrate refeeding in Anorexia Nervosa triggers an INSULIN SURGE that drives PO4, K+, and Mg2+ into cells -> severe HYPOPHOSPHATEMIA, cardiac arrhythmias, rhabdomyolysis, heart failure, seizures.
6-24h: tremor/anxiety; 12-48h: generalized tonic-clonic seizures; 48-72h: alcoholic hallucinosis (intact orientation); 48-96h: Delirium Tremens (confusion, autonomic instability, fever/tachycardia) -> Benzodiazepines (LOT in cirrhosis!).
Opioid overdose: coma, respiratory depression (<12/min), pinpoint miosis -> IV Naloxone. Opioid withdrawal: yawning, lacrimation, piloerection, diarrhea, mydriasis -> Buprenorphine/Methadone. PCP: violent agitation + rotary/vertical nystagmus.
Somatic Symptom: excessive anxiety over real symptoms (>=6 mo). Illness Anxiety: fear of serious illness with minimal/no symptoms. Conversion: neuro deficit incompatible with anatomy. Factitious: intentional faking for sick role (primary gain) vs Malingering (secondary gain).
N2: sleep spindles & K-complexes (bruxism). N3: delta slow-wave (sleepwalking, night terrors, bedwetting). REM: beta/sawtooth waves, dreaming, atonia (REM behavior disorder = alpha-synucleinopathy). Narcolepsy: orexin deficiency + cataplexy -> Modafinil.
Anxiety & Trauma-Related Disorders Master Comparison
DSM-5-TR Anxiety, Obsessive-Compulsive, and Trauma/Stressor-Related Disorders are differentiated by the trigger specificity of the anxiety (generalized daily worries vs. unprovoked discrete panic surges vs. social scrutiny vs. intrusive ego-dystonic obsessions), strict chronological duration cutoffs (≥6 months for GAD/Phobias, ≥1 month for Panic Disorder and PTSD, 3 days to 1 month for Acute Stress Disorder), and evidence-based psychotherapy plus SSRI/SNRI pharmacotherapy.
Comprehensive psychiatric board mastery also integrates Suicide Risk Assessment & Safety Planning (evaluating SAD PERSONS suicide risk factors, suicidal ideation plan intent, and lethal means restriction), eating disorders (Anorexia Nervosa vs. Bulimia Nervosa vs. Binge-Eating Disorder), somatic and factitious disorders (Somatic Symptom Disorder, Illness Anxiety Disorder, Conversion Disorder, Factitious Disorder, and Malingering), child/adolescent neurodevelopmental disorders (Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder [ADHD], Tourette Disorder, and Oppositional Defiant vs. Conduct Disorder), and sleep-wake disorders (Narcolepsy caused by lateral hypothalamic orexin/hypocretin neuron deficiency, presenting with excessive daytime sleepiness, cataplexy, hypnagogic/hypnopompic hallucinations, and sleep paralysis; treated with modafinil and sodium oxybate).
| Disorder | Core Diagnostic Features | Duration Requirement | First-Line Evidence-Based Treatment |
|---|---|---|---|
| Generalized Anxiety Disorder (GAD) | Excessive, uncontrollable worry about everyday issues ± ≥ 3 somatic symptoms: fatigue, restlessness, poor concentration, irritability, muscle tension, sleep disturbance | ≥ 6 Months | SSRIs or SNRIs (Sertraline, Escitalopram, Duloxetine) + Cognitive Behavioral Therapy (CBT); Buspirone as non-benzodiazepine adjuvant |
| Panic Disorder | Recurrent unexpected panic attacks (intense fear peaking in minutes: palpitations, diaphoresis, dyspnea, chest pain, fear of dying) followed by ≥ 1 month of persistent worry about further attacks or agoraphobia | ≥ 1 Month of anticipatory dread or behavioral change | SSRIs / SNRIs + CBT; Benzodiazepines (Alprazolam, Clonazepam) reserved only for acute abortive management, avoiding long-term dependence |
| Post-Traumatic Stress Disorder (PTSD) | Exposure to actual or threatened death, serious injury, or sexual violence; 4 symptom clusters: 1. Intrusion (nightmares, flashbacks), 2. Avoidance of trauma cues, 3. Negative mood/cognition, 4. Hyperarousal (hypervigilance, exaggerated startle) | > 1 Month | SSRIs (Sertraline, Paroxetine) or Venlafaxine + Trauma-focused CBT / Prolonged Exposure; Prazosin (alpha-1 blocker) for trauma-related nightmares |
| Obsessive-Compulsive Disorder (OCD) | Recurrent intrusive thoughts/urges causing distress (obsessions) relieved by repetitive mental or behavioral acts (compulsions); ego-dystonic | Time-consuming (> 1 hr/day) or causing significant impairment | High-dose SSRIs (Fluoxetine, Fluvoxamine, Sertraline) + Exposure and Response Prevention (ERP); Clomipramine (TCA) for refractory cases |
Anxiety & Trauma Chronology: Panic Disorder (>=1m) vs. GAD (>=6m) vs. Acute Stress Disorder (3d–1m) vs. PTSD (>1m & Prazosin)
Memorize the diagnostic duration thresholds and first-line treatments across the anxiety and trauma spectrum: (1) Panic Disorder requires recurrent, unexpected (unprovoked) Panic Attacks—abrupt surges of intense fear reaching a peak within 10 minutes with ≥4 of 13 autonomic/cognitive symptoms (palpitations, diaphoresis, trembling, dyspnea, chest pain, paresthesias, derealization, fear of dying/going crazy)—followed by ≥1 MONTH of persistent worry about having additional attacks or maladaptive avoidance behavior (frequently coexisting with Agoraphobia: fear of being in ≥2 situations [public transit, open spaces, enclosed shops, crowds, or outside the home alone] where escape might be difficult). Note that acute panic attacks are aborted with short-term Benzodiazepines (alprazolam/lorazepam), whereas long-term first-line maintenance therapy is an SSRI/SNRI + Cognitive-Behavioral Therapy (CBT)! (2) Generalized Anxiety Disorder (GAD) requires excessive, difficult-to-control worry about multiple everyday domains (finances, work, health, family) occurring more days than not for ≥6 MONTHS, accompanied by ≥3 of 6 somatic symptoms (restlessness, easy fatigability, difficulty concentrating, irritability, muscle tension, sleep disturbance; only ≥1 required in children); treat with First-Line SSRIs (escitalopram/sertraline), SNRIs (venlafaxine/duloxetine), or Buspirone (a 5-HT1A partial agonist that takes 2–4 weeks to work, causes zero sedation/addiction/withdrawal, and does NOT interact with alcohol!). (3) Social Anxiety Disorder (fear of scrutiny/humiliation in social interactions for ≥6 months) is treated with SSRIs/CBT for generalized disease, or Low-Dose Propranolol (beta-blocker) 30–60 minutes prior to the event for Performance-Only Social Anxiety (stage fright)! (4) Trauma-Related Disorders following exposure to actual or threatened death, serious injury, or sexual violence (featuring intrusion symptoms, avoidance, negative mood/cognition, and hyperarousal/startle) are separated strictly by the 1-Month Cutoff: Acute Stress Disorder lasts 3 days to 1 month after the trauma (treated with trauma-focused CBT), whereas Post-Traumatic Stress Disorder (PTSD) lasts >1 MONTH (treated with trauma-focused CBT/EMDR + SSRIs/SNRIs, plus the alpha-1 antagonist Prazosin specifically for trauma-related nightmares!). Contrast PTSD with Adjustment Disorder, which occurs within 3 months of a non-life-threatening psychosocial stressor (divorce, job loss, moving) and resolves within 6 months after the stressor ends.
Personality Disorder Clusters (A: Weird, B: Wild, C: Worried), OCD (ERP + SSRI/Clomipramine) & Ego Defense Mechanisms
Master the three DSM-5-TR Personality Disorder Clusters (ego-syntonic, inflexible lifelong traits beginning by early adulthood): Cluster A ('Weird' / Odd-Eccentric — Accusatory, Aloof, Awkward): Paranoid (pervasive distrust and suspicion of others' motives without fixed psychotic delusions), Schizoid (voluntary social detachment, prefers solitude, restricted emotional expression, indifferent to praise/criticism—content being alone!), and Schizotypal (eccentric behavior, odd magical thinking/superstitions, ideas of reference, and social anxiety—desires relationships but fears them due to paranoia). Cluster B ('Wild' / Dramatic-Emotional-Erratic — Bad, Borderline, Flamboyant, Must-be-best): Antisocial (pervasive disregard for and violation of the rights of others, criminality, deceitfulness, lack of remorse; CANNOT be diagnosed until Age ≥18 years, and requires evidence of Conduct Disorder BEFORE Age 15!), Borderline (frantic efforts to avoid abandonment, unstable interpersonal relationships alternating between idealization and devaluation ['Splitting' defense mechanism!], chronic feelings of emptiness, impulsivity, and recurrent suicidal/self-mutilating cutting behavior—First-Line Treatment is Dialectical Behavior Therapy [DBT]!), Histrionic (excessive emotionality and attention-seeking, sexually seductive/provocative, shallow shifting emotions), and Narcissistic (grandiose sense of self-importance, need for admiration, lack of empathy, fragile self-esteem reacting with rage to criticism). Cluster C ('Worried' / Anxious-Fearful — Cowardly, Clingy, Compulsive): Avoidant (hypersensitive to rejection/criticism, feelings of inadequacy, avoids social interaction despite desiring relationships!), Dependent (submissive, clingy need to be taken care of, fears separation), and Obsessive-Compulsive Personality Disorder (OCPD) (pervasive preoccupation with orderliness, perfectionism, rules, and control that is EGO-SYNTONIC [the patient believes their rigid perfectionism is right and normal!]—contrast with Obsessive-Compulsive Disorder [OCD], which features intrusive, anxiety-provoking, EGO-DYSTONIC Obsessions and repetitive neutralizing Compulsions, treated with Exposure and Response Prevention [ERP] CBT + High-Dose SSRIs or the tricyclic Clomipramine!).
Alcohol & Substance Withdrawal Syndromes
Substance intoxication and withdrawal syndromes obey a fundamental neurophysiological inverse law: Central Nervous System (CNS) Depressants (Alcohol, Benzodiazepines, Barbiturates, and Opioids) cause sedation and autonomic suppression during acute intoxication, followed by sympathetic hyperarousal during withdrawal—and uniquely, ONLY CNS depressants that act on the GABAA chloride channel (Alcohol, Benzodiazepines, and Barbiturates) cause directly life-threatening withdrawal seizures and Delirium Tremens. Conversely, CNS Stimulants (Cocaine, Amphetamines, MDMA) cause acute sympathomimetic intoxication and a non-lethal 'crash' (hypersomnia, hyperphagia, depression) during withdrawal.
| Substance | Withdrawal Timeline & Symptoms | Life-Threatening Risks | Medical Management Protocol |
|---|---|---|---|
| Alcohol Withdrawal | 6–12h: Tremulousness, anxiety, GI upset; 12–24h: Alcoholic hallucinosis (auditory/visual, sensorium intact); 24–48h: Generalized tonic-clonic seizures; 48–96h: Delirium Tremens (DTs) | Delirium Tremens: Severe confusion, gross agitation, hyperthermia, hypertension, diaphoresis; 5% mortality from cardiovascular collapse | Symptom-triggered long-acting Benzodiazepines (Diazepam, Chlordiazepoxide); use LOT (Lorazepam, Oxazepam, Temazepam) in hepatic impairment; IV fluids + Thiamine (BEFORE glucose to prevent Wernicke) |
| Opioid Withdrawal | 6–12 hours (heroin) or 24–48 hours (methadone): Dysphoria, rhinorrhea, lacrimation, piloerection ('cold turkey'), yawning, severe abdominal cramping, diarrhea, mydriasis | Severely distressing but NOT inherently fatal (unless severe dehydration/electrolyte collapse from vomiting/diarrhea) | Buprenorphine-Naloxone or Methadone; symptomatic relief with Clonidine (alpha-2 agonist relieves autonomic hyperactivity), Loperamide, and Ondansetron |
| Benzodiazepine Withdrawal | Onset depends on half-life (short: Alprazolam within 24h; long: Diazepam after several days); Anxiety, tremors, insomnia, perceptual distortions, delirium, seizures | Status epilepticus, autonomic hyperarousal, psychosis; high mortality if untreated | Gradual taper with long-acting benzodiazepine (Diazepam or Clonazepam) over weeks/months |
The Alcohol Withdrawal Timeline (6h Tremors -> 12–48h Seizures -> 48–96h Delirium Tremens), LOT Benzodiazepines & Wernicke-Korsakoff (Thiamine BEFORE Glucose)
Chronic ethanol consumption enhances inhibitory GABAA receptor chloride influx while upregulating excitatory NMDA glutamate receptors; abrupt cessation leaves NMDA glutamate excitation completely unopposed, driving a strict 4-stage chronological withdrawal timeline that is tested on every board exam: (1) Stage 1 — Mild Autonomic Withdrawal (6 to 24 hours after last drink): anxiety, insomnia, diaphoresis, tachycardia, hypertension, GI upset, and coarse hand tremors (patient has an intact sensorium). (2) Stage 2 — Alcoholic Hallucinosis (12 to 48 hours): transient visual, tactile ('formication'—bugs crawling on skin), or auditory hallucinations with INTACT ORIENTATION and stable vital signs (this is what separates Alcoholic Hallucinosis from Delirium Tremens!). (3) Stage 3 — Alcohol Withdrawal Seizures (12 to 48 hours): generalized tonic-clonic seizures (single or brief cluster). (4) Stage 4 — Delirium Tremens (DTs, 48 to 96 hours [2–4 days] after last drink; 5%–15% mortality!): defined by the onset of global DELIRIUM (disorientation, confusion, agitation), severe autonomic instability (fever, malignant tachycardia/hypertension, drenching diaphoresis), and visual/tactile hallucinations. First-line treatment for ALL stages of alcohol withdrawal is a Symptom-Triggered (CIWA-Ar) Long-Acting Benzodiazepine (Chlordiazepoxide or Diazepam)—EXCEPT in patients with advanced Cirrhosis / Liver Failure or the Elderly, where you MUST use a 'LOT' Benzodiazepine (Lorazepam, Oxazepam, or Temazepam) because LOT benzodiazepines undergo direct Phase II glucuronidation without Phase I CYP450 oxidation or active metabolites! Finally, never forget the #1 Emergency Department Resuscitation Rule in Alcoholism: always administer Intravenous Thiamine (Vitamin B1) BEFORE or concomitantly with Dextrose (Glucose)! Infusing glucose first consumes the patient's last trace of thiamine pyrophosphate cofactor (for pyruvate dehydrogenase, α-ketoglutarate dehydrogenase, and transketolase), precipitating acute Wernicke Encephalopathy (triad: Confusion, Ophthalmoplegia/Nystagmus [CN VI palsy], and Truncal Ataxia; reversible with IV thiamine) and irreversible Korsakoff Syndrome (bilateral mammillary body and anterior/mediodorsal thalamic hemorrhage/necrosis causing permanent anterograde/retrograde amnesia with Confabulation!). Long-term alcohol relapse prevention uses Naltrexone (μ-opioid antagonist reducing cravings; contraindicated in acute hepatitis or opioid use), Acamprosate (NMDA modulator safe in liver disease; avoid in severe renal failure CrCl <30), or Disulfiram (aldehyde dehydrogenase inhibitor).
Opioid Intoxication (Naloxone) vs. Withdrawal (Piloerection/Yawning/Diarrhea), PCP (Rotary Nystagmus) & Relapse Pharmacotherapy
Compare the toxidromes and treatments of Opioids, Stimulants, and Hallucinogens: (1) Opioid Intoxication & Withdrawal: acute opioid overdose (heroin, fentanyl, oxycodone, methadone) produces the classic Triad: Coma/CNS Depression, Pinpoint Pupils (Miosis; exception: Meperidine causes normal/dilated pupils and seizures via normeperidine!), and Respiratory Depression (decreased respiratory rate is the #1 predictor of mortality, caused by blunted medullary chemoreceptor sensitivity to CO2), accompanied by bradycardia, hypotension, hypothermia, and decreased bowel sounds—treated immediately with airway support and IV/Intranasal Naloxone (competitive μ-opioid antagonist with a short 30–60 minute half-life, so repeat dosing is often required for long-acting methadone/fentanyl overdoses!). Conversely, Opioid Withdrawal is intensely uncomfortable ('flu-like') but NEVER life-threatening in adults (exception: life-threatening in Neonatal Abstinence Syndrome, which presents with high-pitched crying, jitteriness, sneezing, Tachypnea, diarrhea, and seizures, treated with Oral Morphine or Methadone!), presenting with Mydriasis (dilated pupils), Rhinorrhea, Lacrimation, Yawning, Piloerection ('gooseflesh / cold turkey'), Myalgias/Arthralgias, Abdominal Cramps, Nausea/Vomiting, Diarrhea, and Tachycardia/Hypertension. Treat acute opioid withdrawal symptomatically with Clonidine or Lofexidine (central α2-agonists reducing locus coeruleus sympathetic outflow) plus antiemetics/loperamide, and treat Opioid Use Disorder long-term with Medication-Assisted Treatment (reduces mortality by >50%!): Buprenorphine-Naloxone (Suboxone: partial μ-opioid agonist that must be started only when the patient is already in mild-to-moderate withdrawal to avoid precipitating acute withdrawal!) OR Methadone (full μ-opioid agonist; watch for QT prolongation!). (2) Stimulants & Hallucinogens: Cocaine (blocks presynaptic DAT/NET/SERT reuptake) and Amphetamines (displace vesicular catecholamines and block reuptake) cause agitation, paranoia, mydriasis, diaphoresis, tachycardia, hypertension, angina, and nasal septum perforation (cocaine) or bruxism/meth-mouth (methamphetamine)—treat acute agitation and hypertension with IV Benzodiazepines (and phentolamine/nitrates; avoid pure beta-blockers!). Phencyclidine (PCP, 'Angel Dust') is an NMDA glutamate receptor antagonist that uniquely causes violent belligerence, superhuman strength with complete insensitivity to pain, dissociative psychosis, hypertension/tachycardia, and pathognomonic ROTARY (VERTICAL AND HORIZONTAL) NYSTAGMUS (treat with a quiet room and Benzodiazepines or Haloperidol). Cannabis Intoxication presents with conjunctival injection (red eyes), increased appetite ('munchies'), dry mouth, tachycardia, and slowed time perception (chronic heavy use causes Cannabinoid Hyperemesis Syndrome: cyclic intractable vomiting uniquely relieved by compulsive hot showers and topical capsaicin!).
Personality Disorders Master Matrix: Clusters A, B & C and Defense Mechanisms
Personality Disorders are enduring, inflexible, and pervasive patterns of inner experience and behavior that deviate markedly from cultural expectations, begin by adolescence or early adulthood, remain stable across time and situations, and are ego-syntonic (patients perceive their maladaptive traits as natural and reasonable, attributing interpersonal conflicts entirely to others—unlike the ego-dystonic distress of OCD or anxiety disorders). DSM-5 groups the 10 personality disorders into three clusters: Cluster A ('Weird' — Odd/Eccentric, genetically linked to psychotic disorders), Cluster B ('Wild' — Dramatic, Emotional, or Erratic, linked to mood/substance disorders), and Cluster C ('Worried' — Anxious or Fearful). Mastering the subtle boundary distinctions between look-alike pairs (Schizoid vs. Avoidant; Schizotypal vs. Schizophrenia; Antisocial vs. Narcissistic; OCPD vs. OCD) is essential for board exams.
| Cluster & Disorder | Core Diagnostic Hallmark | Crucial Board Distinction (Look-Alike Contrast) | Signature Defense Mechanism & First-Line Therapy |
|---|---|---|---|
| Cluster A: Paranoid, Schizoid, Schizotypal (Odd / Eccentric) | • Paranoid: Pervasive distrust/suspicion of others, holds grudges, reads hidden threats into benign remarks. • Schizoid: Voluntary social detachment, prefers solitude, restricted flat emotional expression, indifferent to praise or criticism. • Schizotypal: Eccentric dress/speech, magical thinking (superstition, clairvoyance, sixth sense), ideas of reference, social anxiety due to paranoid fears | Schizoid vs. Avoidant: Schizoid has zero desire for social relationships and is content alone; Avoidant (Cluster C) desperately wants relationships but avoids them due to paralyzing fear of rejection/embarrassment. Schizotypal vs. Schizophrenia: Schizotypal has odd beliefs/magical thinking, NOT fixed delusions or persistent hallucinations | Paranoid Defense: Projection (attributing one's own unacceptable hostile impulses to others). Rx: Supportive psychotherapy (low-dose atypical antipsychotics for severe Schizotypal cognitive/perceptual distortion) |
| Cluster B: Borderline Personality Disorder (BPD) | Unstable interpersonal relationships, unstable self-image, frantic efforts to avoid real/imagined abandonment, chronic feelings of emptiness, impulsivity, and recurrent suicidal gestures or non-suicidal self-injury (cutting/burning) | BPD vs. Bipolar Disorder: BPD mood swings (intense anger, dysphoria, anxiety) are reactive to interpersonal triggers and last hours to a few days, whereas Bipolar mania/hypomania lasts ≥4–7 consecutive days autonomously | Signature Defense: Splitting (viewing people, including medical staff, as either 'all good/idealized' or 'all bad/devalued'). First-Line Rx: Dialectical Behavior Therapy (DBT) (combines CBT, mindfulness, distress tolerance, and emotion regulation) |
| Cluster B: Antisocial Personality Disorder (ASPD) | Pervasive disregard for and violation of the rights of others, deceitfulness, manipulation for personal profit, impulsivity, criminality, and complete lack of remorse | Mandatory Age Rule: Patient MUST be Age ≥ 18 years WITH evidence of Conduct Disorder before Age 15 (if patient is <18 yr, diagnose Conduct Disorder; if mild defiant behavior toward authority without violence/property destruction, diagnose Oppositional Defiant Disorder) | Defense: Acting out. Comorbidity: High rates of severe substance use disorder; monitor for malingering |
| Cluster B: Histrionic & Narcissistic | • Histrionic: Excessive emotionality and attention-seeking; uncomfortable when not center of attention, provocative/seductive behavior, theatrical shallow emotions, considers relationships more intimate than they actually are. • Narcissistic: Grandiosity, sense of entitlement, need for excessive admiration, lacks empathy, fragile self-esteem (reacts to criticism with narcissistic rage) | Narcissistic vs. Antisocial: Both exploit others and lack empathy, but Narcissistic patients exploit others to boost status and admiration (without criminality), whereas Antisocial patients exploit for material gain or pleasure | Histrionic Defense: Regression, somatization, dissociation. Rx: Psychodynamic psychotherapy |
| Cluster C: Avoidant, Dependent, Obsessive-Compulsive (OCPD) (Anxious / Fearful) | • Avoidant: Social inhibition, feelings of inadequacy, hypersensitivity to negative evaluation/rejection (desires closeness!). • Dependent: Submissive clinging behavior, fears separation, needs others to assume responsibility for major life decisions. • OCPD: Preoccupation with orderliness, perfectionism, rules, lists, and control at the expense of flexibility and task completion; stubborn, frugal, reluctant to delegate | OCPD vs. OCD: OCPD is EGO-SYNTONIC (patient values their perfectionism and has NO true obsessions or ritualistic compulsions); OCD is EGO-DYSTONIC (patient recognizes intrusive thoughts/compulsions as distressing and irrational) | OCPD Defense: Isolation of affect, intellectualization. Rx: Cognitive-Behavioral Therapy (CBT) |
Immature vs. Neurotic vs. Mature Ego Defense Mechanisms
Unconscious psychological defense mechanisms managed by the ego are heavily tested alongside personality disorders: Mature Defenses (Sublimation, Altruism, Humor, Suppression): Sublimation channels unacceptable drives into socially constructive outlets (an aggressive teenager becomes a championship rugby player), while Suppression is the conscious, intentional postponement of anxiety-provoking thoughts (contrast with Repression, which is unconscious blocking of thoughts). Neurotic Defenses: Displacement (yelling at a spouse or kicking the dog after being berated by the attending physician), Reaction Formation (transforming an unacceptable impulse into its exact opposite, such as someone harboring unconscious resentment toward a colleague acting overly syrupy and complimentary), Isolation of Affect (describing a horrific trauma in cold, detached clinical detail without emotion), and Undoing (compulsive handwashing to 'cancel out' an intrusive thought). Immature Defenses: Splitting (Borderline PD), Projection (Paranoid PD), Passive-Aggression, and Regression (a 6-year-old resumes bedwetting and thumb-sucking when a newborn sibling arrives).
Trauma and PTSD Psychotherapy & Pharmacotherapy Algorithm Reference
Post-Traumatic Stress Disorder (PTSD — intrusion, avoidance, negative alterations in mood/cognition, and hyperarousal persisting >1 month; versus Acute Stress Disorder if lasting 3 days to 1 month) often co-occurs with Borderline Personality Disorder and Substance Use Disorders. First-line treatment combines trauma-focused CBT (prolonged exposure, EMDR) with SSRIs (sertraline, paroxetine) or SNRIs (venlafaxine), plus the α1-antagonist Prazosin specifically for trauma-related nightmares.
De-Escalation of the Hospitalized Patient with Splitting or Narcissistic Rage
When a hospitalized patient with Borderline Personality Disorder exhibits splitting—praising the physician as 'the only competent doctor in this hospital' while demanding that the 'cruel, incompetent' nursing staff be fired—the correct management is to validate the patient's emotional distress while maintaining clear, consistent boundaries, avoiding taking sides, and holding regular multidisciplinary team meetings so all staff communicate a unified treatment plan. When a patient with Narcissistic Personality Disorder demeans a resident's credentials and demands the department chair, acknowledge the patient's desire for the highest quality care without becoming defensive.
Eating Disorders: Anorexia Nervosa, Bulimia Nervosa, Binge-Eating & Refeeding Syndrome
Anorexia Nervosa and Bulimia Nervosa share a core psychopathology: an overvaluation of body shape and weight coupled with an intense fear of gaining weight. However, they are strictly separated by a single objective clinical threshold: Body Mass Index (BMI). Patients with Anorexia Nervosa maintain a significantly low body weight (BMI < 18.5 kg/m2 in adults, or <5th percentile in children/adolescents)—even if they engage in binge-eating and purging behaviors (Anorexia Nervosa, Binge-Eating/Purging subtype vs. Restricting subtype)! Conversely, patients with Bulimia Nervosa have a NORMAL or overweight BMI (≥ 18.5 kg/m2) and engage in recurrent episodes of binge eating (consuming a large amount of food in a discrete 2-hour window with a sense of lack of control) followed by compensatory behaviors (self-induced vomiting, laxative/diuretic misuse, fasting, or excessive exercise) at least once per week for ≥ 3 months.
| Feature / Parameter | Anorexia Nervosa | Bulimia Nervosa | Binge-Eating Disorder |
|---|---|---|---|
| BMI & Core Diagnostic Rule | BMI < 18.5 kg/m2 (Restricting subtype vs. Binge-eating/Purging subtype); distorted body image, denial of illness severity | BMI ≥ 18.5 kg/m2 (Normal or Overweight!); binge eating + compensatory purging/exercise ≥1x/week for ≥3 months | Usually Overweight or Obese; recurrent binge eating (≥1x/wk for ≥3 mo) with distress/guilt and NO compensatory purging |
| Physical Exam Stigmata | Severe cachexia, fine downy body hair (lanugo), hypothermia, sinus bradycardia & orthostatic hypotension, dry yellow carotenemic skin, peripheral edema | Bilateral parotid gland enlargement (sialadenosis) ('chipmunk cheeks' + elevated serum amylase), erosion of lingual dental enamel, calluses/scars on dorsum of knuckles (Russell sign) | Elevated BMI, metabolic syndrome features; lacks parotid hypertrophy, dental erosion, or Russell sign |
| Endocrine & Bone Complications | Hypogonadotropic hypogonadism (↓ GnRH → ↓ LH/FSH → ↓ Estrogen → secondary amenorrhea & severe early Osteoporosis!), Euthyroid Sick Syndrome (↓ T3, ↑ reverse T3, normal/low TSH), ↑ Cortisol, ↑ GH | Irregular menses or normal ovulatory cycles; bone mineral density is typically preserved compared to anorexia nervosa | Insulin resistance, type 2 diabetes mellitus, dyslipidemia |
| Electrolyte & Acid-Base Profile | Starvation ketosis, leukopenia/anemia/thrombocytopenia (gelatinous bone marrow transformation); Refeeding Syndrome: ↓↓ Phosphate, ↓ K+, ↓ Mg2+ | Vomiting: Hypochloremic, Hypokalemic Metabolic Alkalosis (contraction + secondary hyperaldosteronism; low urine Cl− <20 mEq/L). Laxative abuse: Normal anion-gap Metabolic Acidosis | Normal electrolytes |
| First-Line Management & Contraindications | 1st Line: Nutritional rehabilitation + Family-Based Therapy (Maudsley method in adolescents) / CBT (SSRIs are ineffective in underweight state; low-dose Olanzapine may aid weight gain). Hospitalize if: HR <40–50 bpm, BP <80/50, orthostasis, K+ <3.0, PO4 <2.0, or BMI <15 | 1st Line: Cognitive-Behavioral Therapy (CBT) + High-dose SSRI (Fluoxetine 60 mg/day is FDA-approved!). ABSOLUTE CONTRAINDICATION: Bupropion (precipitates generalized seizures!) | 1st Line: CBT / Behavioral weight loss; Pharmacotherapy: SSRIs, Lisdexamfetamine (FDA-approved stimulant), or Topiramate |
Refeeding Syndrome Pathophysiology & Prevention Protocol
During prolonged starvation in Anorexia Nervosa, basal insulin secretion is suppressed while glucagon and cortisol maintain euglycemia via lipolysis and ketogenesis; total body stores of intracellular electrolytes (phosphate, potassium, magnesium) and thiamine become severely depleted even though serum concentrations may appear deceptively normal. When rapid carbohydrate refeeding is initiated, the sudden glucose load triggers a massive pancreatic insulin surge. Insulin stimulates cellular glucose uptake, glycolysis (consuming inorganic phosphate to synthesize ATP and 2,3-BPG), and the Na+/K+-ATPase pump—driving phosphate, potassium, and magnesium rapidly into cells while promoting renal sodium and water retention. The resulting profound hypophosphatemia (<1.5 mg/dL) causes myocardial ATP depletion, ventricular arrhythmias, acute decompensated heart failure, diaphragmatic respiratory failure, rhabdomyolysis, hemolysis, and seizures. Prevention requires starting nutrition gradually (1,200–1,400 kcal/day), administering prophylactic thiamine, and monitoring/repleting serum phosphate, potassium, and magnesium daily.
Medical Indications for Inpatient Hospitalization in Anorexia Nervosa
Cardiac complications (arrhythmias and sudden cardiac death from QT prolongation, myocardial atrophy, or electrolyte derangements) and suicide are the two leading causes of mortality in Anorexia Nervosa. Immediate inpatient medical stabilization is mandatory when any of the following instability criteria are present: severe bradycardia (heart rate <40–50 bpm daytime or <45 bpm at night), hypotension (<80–90/50 mmHg), orthostatic pulse increase >20 bpm or BP drop >10–20 mmHg, hypothermia (<35.5°C / 96°F), severe electrolyte abnormalities (hypokalemia, hypophosphatemia), QTc prolongation, or weight <75% of ideal body weight (BMI <15 kg/m2).
Osteoporosis Management in Anorexia Nervosa / Female Athlete Triad
In Anorexia Nervosa and the Female Athlete Triad (low energy availability, functional hypothalamic amenorrhea, and low bone mineral density), GnRH suppression leads to hypoestrogenemia, uncoupled osteoclast resorption, and high cortisol, causing rapid, irreversible loss of trabecular bone density and stress fractures. Crucially, oral contraceptive pills (OCPs) DO NOT restore bone mineral density in anorexia nervosa (and may falsely reassure patient and clinician by inducing artificial withdrawal bleeds); the ONLY effective treatment to rebuild bone density is weight restoration and resumption of spontaneous ovulatory menses supplemented with calcium and vitamin D.
Substance Intoxication, Overdose Antidotes & Withdrawal Syndromes Master Matrix
Substance-related vignettes on COMLEX and USMLE require rapid differentiation between Central Nervous System Depressants (Alcohol, Benzodiazepines, Barbiturates, Opioids, Inhalants) and CNS Stimulants / Hallucinogens (Cocaine, Amphetamines, Phencyclidine [PCP], LSD, MDMA, Synthetic Cathinones, Cannabis). A fundamental clinical rule governs withdrawal lethality: GABAA-ergics (Alcohol, Benzodiazepines, Barbiturates) cause LIFE-THREATENING withdrawal characterized by unopposed glutamatergic NMDA excitation, autonomic storm, status epilepticus, and Delirium Tremens. Conversely, Opioid withdrawal is intensely uncomfortable ('flu-like misery') but is NEVER life-threatening in a healthy adult (with the critical exception of fetal demise in pregnant patients, where acute maternal opioid withdrawal induces uterine contractions and placental abruption—mandating maintenance therapy with Methadone or Buprenorphine during pregnancy!).
| Substance | Acute Intoxication Signs & Mechanism | Withdrawal Syndrome & Timeline | Overdose Antidote & Withdrawal / Relapse Pharmacotherapy |
|---|---|---|---|
| Alcohol (Ethanol) | Potentiates GABAA (Cl− influx) & inhibits NMDA glutamate; disinhibition, slurred speech, ataxia, stupor, hypoglycemia, AST:ALT >2:1 | • 6–24h: Tremors, anxiety, insomnia, diaphoresis, palpitations. • 12–48h: Generalized tonic-clonic seizures. • 48–72h: Alcoholic hallucinosis (visual/tactile hallucinations with INTACT orientation and stable vitals!). • 48–96h: Delirium Tremens (DTs) (global confusion/delirium, agitation, severe autonomic instability: fever, tachycardia, HTN; 5–15% mortality!) | Withdrawal Rx: Long-acting Benzodiazepines (Chlordiazepoxide, Diazepam); if liver cirrhosis → 'LOT' (Lorazepam, Oxazepam, Temazepam)! Relapse Prevention: 1) Naltrexone (μ-opioid antagonist; reduces cravings; check LFTs/no opioids); 2) Acamprosate (NMDA modulator; safe in liver disease, avoid in severe renal disease); 3) Disulfiram (inhibits aldehyde dehydrogenase) |
| Opioids (Heroin, Fentanyl, Oxycodone, Methadone) | μ-opioid receptor agonist: Classic Overdose Triad = CNS Depression (Coma) + Respiratory Depression (<12 breaths/min, #1 cause of death!) + Pinpoint Pupils (Miosis), bradycardia, decreased bowel sounds | Dysphoria, severe myalgias/arthralgias, abdominal cramping, diarrhea, nausea/vomiting, lacrimation, rhinorrhea, yawning, piloerection ('cold turkey'), diaphoresis, and pupillary MYDRIASIS (not fatal in adults) | Overdose Antidote: IV/Intranasal Naloxone (short half-life; watch for recurrent sedation). Withdrawal / OUD Maintenance: Buprenorphine-Naloxone (Suboxone — partial μ-agonist; wait until mild withdrawal to avoid precipitated withdrawal!) or Methadone (full agonist; QT prolongation); Clonidine / Lofexidine (α2-agonist) + Loperamide for symptomatic relief |
| Benzodiazepines & Barbiturates | GABAA receptor allosteric modulators (BZD increases Cl− channel frequency; Barbiturates increase opening duration → much higher fatal respiratory depression risk!). Classic BZD Overdose: Slurred speech/ataxia/somnolence with NORMAL respiratory rate and normal pupils (unless co-ingested with alcohol/opioids) | Rebound anxiety, tremor, insomnia, perceptual disturbances, autonomic hyperactivity, and life-threatening generalized tonic-clonic seizures | BZD Overdose: Supportive care (avoid Flumazenil in chronic BZD users or TCA co-ingestion because it precipitates refractory status epilepticus!). Withdrawal Rx: Gradual taper with long-acting benzodiazepine or phenobarbital |
| Cocaine & Amphetamines (Methamphetamine, MDMA) | Cocaine: Blocks reuptake of DA, NE, 5-HT (+ Na+ channel blocker). Amphetamines: Release vesicular DA/NE. Signs: Euphoria, agitation, paranoid psychosis, mydriasis, diaphoresis, tachycardia, hypertension, chest pain (coronary vasospasm), nasal septal perforation, formication ('meth mites'); MDMA: hyperthermia, bruxism, hyponatremia (SIADH + water intake) | 'Post-use Crash': Severe depression/suicidality, hypersomnolence, vivid unpleasant dreams, hyperphagia (increased appetite!), psychomotor retardation, intense cravings | Acute Intoxication / Chest Pain / Agitation: IV Benzodiazepines (Lorazepam/Diazepam — 1st line!) + Phentolamine/Nitroglycerin for hypertension. (Avoid pure β-blockers like propranolol due to theoretical unopposed α1 vasoconstriction) |
| Phencyclidine (PCP / 'Angel Dust') | Noncompetitive NMDA glutamate receptor antagonist; belligerence, violent impulsivity, superhuman strength/insensitivity to pain, psychosis, tachycardia/HTN, and pathognomonic rotary, vertical, or horizontal Nystagmus! | Minimal physical withdrawal; depression or cognitive slowing | Rx: Place in quiet low-stimulus environment + IM/IV Benzodiazepines (Lorazepam) (or Haloperidol for severe psychosis); monitor CK for rhabdomyolysis |
| Cannabis, LSD & Synthetic Cannabinoids ('K2/Spice') | Cannabis (THC — CB1 receptor): Conjunctival injection (red eyes), increased appetite ('munchies'), dry mouth, slowed time perception; Cannabinoid Hyperemesis Syndrome (cyclic vomiting relieved by hot showers; Rx: cessation + haloperidol/capsaicin). K2/Spice: Full CB1 agonist → severe agitation, psychosis, tachycardia, seizures (negative routine urine THC screen!). LSD (5-HT2A agonist): Visual hallucinations, synesthesia, mydriasis | Cannabis Withdrawal: Irritability, anxiety, insomnia, decreased appetite/weight loss, restlessness | Reassurance in a calm environment; benzodiazepines if severe panic/agitation |
Differentiating Alcoholic Hallucinosis vs. Delirium Tremens (DTs)
A favorite NBOME and NBME clinical distinction compares a patient 36 hours after his last drink who sees bugs crawling on the wall (formication) or hears voices, yet is fully alert, oriented to person, place, and time, and has stable vital signs (Alcoholic Hallucinosis) versus a patient 72 hours after his last drink who is globally confused, disoriented, severely agitated, febrile (39.1°C), tachycardic (140 bpm), and diaphoretic (Delirium Tremens). The presence of delirium (waxing-and-waning sensorium/disorientation) plus severe autonomic instability defines Delirium Tremens, which carries a 5–15% mortality rate and requires ICU admission and aggressive symptom-triggered IV benzodiazepines (lorazepam or diazepam).
Tobacco (Nicotine) Cessation Pharmacotherapy Hierarchy
For patients ready to quit smoking, combining behavioral counseling with pharmacotherapy doubles abstinence rates. The single most effective pharmacologic agent for smoking cessation is Varenicline (a partial agonist at α4β2 nicotinic acetylcholine receptors that stimulates dopamine release to prevent cravings/withdrawal while competitively blocking nicotine from binding; safe in stable psychiatric patients, monitor for vivid dreams/nausea). Second-line options include Combined Nicotine Replacement Therapy (NRT)—pairing a long-acting transdermal nicotine patch (basal level) with a short-acting nicotine gum, lozenge, or inhaler (breakthrough cravings)—and oral Bupropion (an norepinephrine-dopamine reuptake inhibitor that also prevents post-cessation weight gain; contraindicated in seizure or eating disorders!).
Buprenorphine Precipitated Withdrawal Trap
Because Buprenorphine is a partial μ-opioid receptor agonist with extremely high binding affinity but lower intrinsic efficacy than full agonists (heroin, fentanyl, methadone), administering buprenorphine while a patient still has full opioid agonists bound to their μ-receptors displaces the full agonist and instantly triggers severe precipitated opioid withdrawal. Therefore, clinicians must always wait until the patient is exhibiting objective signs of mild-to-moderate opioid withdrawal (Clinical Opiate Withdrawal Scale [COWS] score ≥8–12) before administering the first induction dose of buprenorphine-naloxone.
Somatic Symptom Disorders, Factitious vs. Malingering & Sleep Architecture / Parasomnias
Disorders at the interface of somatic medicine and psychiatry are organized along a two-axis matrix: (1) Are the symptoms produced unconsciously (involuntarily) or intentionally (consciously)? and (2) Is the motivation internal (psychological sick role) or external (material/financial reward)? In Somatic Symptom Disorder, Illness Anxiety Disorder, and Conversion Disorder (Functional Neurological Symptom Disorder), the symptoms and anxiety are 100% unconscious and involuntary. Conversely, in Factitious Disorder and Malingering, the patient consciously fabricates or induces illness: Factitious Disorder is driven by primary gain (assuming the 'sick role' to receive medical care and sympathy), whereas Malingering is driven by secondary gain (external incentives such as disability payments, avoiding prison/military duty, obtaining opioids, or securing hospital housing).
| Disorder / Sleep Stage | Symptom Production & Core Criteria | Key Clinical / Polysomnographic (EEG) Features | First-Line Management Protocol |
|---|---|---|---|
| Somatic Symptom Disorder vs. Illness Anxiety Disorder | Unconscious production (≥6 months): • Somatic Symptom: ONE OR MORE distressing physical symptoms PRESENT + excessive thoughts, anxiety, and time spent on symptoms. • Illness Anxiety: MINIMAL OR NO physical symptoms present, but intense preoccupation with having/acquiring a serious undiagnosed disease (e.g., cancer, ALS) | Patients frequently visit multiple specialists and remain unconvinced by negative diagnostic workups | Schedule regular, brief visits with a SINGLE primary care physician, perform focused physical exams, avoid unnecessary repetitive diagnostic testing or specialist referrals, and initiate CBT |
| Conversion Disorder (Functional Neurological Symptom Disorder) | Unconscious production of voluntary motor or sensory deficits (paralysis, blindness, mutism, pseudoseizures/PNES, globus sensation) preceded by an acute psychological stressor | Deficit is incompatible with known neuroanatomy (e.g., positive Hoover sign in functional leg weakness; eyes tightly closed resisting opening with normal post-ictal alertness and normal video-EEG in psychogenic non-epileptic seizures); may show la belle indifférence | Validate that the symptoms are real (do NOT confront aggressively), provide education/reassurance, physical therapy, and CBT |
| Factitious Disorder (Munchausen) vs. Malingering | Conscious / Intentional falsification: • Factitious (Imposed on Self or Another/Proxy): Primary gain (desire for the 'sick role'; no external reward). • Malingering: Secondary gain (money, drugs, housing, avoiding jail/work) (NOT a mental illness!) | Factitious clues: Healthcare worker background, surreptitious insulin injection (↑ Insulin with LOW C-peptide!), ingesting levothyroxine (↓ thyroglobulin), fecal contamination of wounds, 'gridiron abdomen' from multiple surgeries. Malingering: Symptoms abruptly resolve once external goal is obtained | Factitious on Self: Avoid unnecessary invasive procedures, coordinate care, gentle non-punitive psychiatric referral. Factitious Imposed on Another (Child/Elder Abuse): Immediately ensure child safety + Report to Child Protective Services (CPS)! |
| Non-REM Sleep Stages: N1, N2 & N3 (Slow-Wave) | • Awake (eyes closed): Alpha waves (8–13 Hz). • N1 (Lightest sleep, 5%): Theta waves (4–7 Hz). • N2 (Largest fraction, 45–55%): Sleep Spindles & K-Complexes; Bruxism (teeth grinding). • N3 (Deepest slow-wave sleep, 15–20%): Delta waves (0.5–3 Hz) | N3 Parasomnias (occur in FIRST 1/3 of night): 1) Sleepwalking (Somnambulism) 2) Sleep Terrors (Night Terrors): Child sits up screaming with autonomic arousal (tachycardia, diaphoresis, mydriasis), inconsolable, and has COMPLETE AMNESIA for the episode the next morning! 3) Nocturnal Enuresis (bedwetting ≥5 yr) | Sleep Terrors / Sleepwalking: Reassurance (outgrown by adolescence), safety locks; low-dose benzodiazepine at bedtime only if dangerous. Enuresis (≥5 yr): 1st line → Behavioral fluid restriction + Enuresis Bedwetting Alarm (#1!); 2nd line → Oral Desmopressin (DDAVP) for short-term sleepovers |
| REM Sleep, Nightmare Disorder & REM Sleep Behavior Disorder (RBD) | REM (20–25% of sleep, increases in second half of night): Beta & 'Sawtooth' EEG waves ('paradoxical sleep'), rapid conjugate eye movements, vivid dreaming, variable pulse/BP, penile/clitoral tumescence, and total skeletal muscle Atonia (mediated by subcoeruleus/medullary glycinergic inhibition) | • Nightmare Disorder: Occurs during REM sleep (second half of night); patient awakens easily and has VIVID RECALL of the frightening dream! • REM Sleep Behavior Disorder (RBD): Loss of normal REM muscle atonia → older male violently kicks, punches, or leaps out of bed acting out dreams; prodrome of α-Synucleinopathies (Parkinson disease, Lewy body dementia, MSA)! | Nightmares: Imagery rehearsal therapy, Prazosin (if PTSD). REM Sleep Behavior Disorder: Bedroom safety padding + Oral Melatonin (1st line, fewer side effects in elderly) or low-dose Clonazepam |
| Narcolepsy | Autoimmune destruction of lateral hypothalamic neurons producing Orexin (Hypocretin-1 / Hypocretin-2); strongly linked to HLA-DQB1*06:02 | Classic Tetrad: 1) Excessive Daytime Sleepiness (sleep attacks); 2) Cataplexy (sudden bilateral loss of muscle tone—jaw drop, knee buckling—triggered by strong emotion/laughter with preserved consciousness; pathognomonic!); 3) Hypnagogic (falling asleep) / Hypnopompic (waking) hallucinations; 4) Sleep paralysis | Dx: Polysomnography + Multiple Sleep Latency Test showing mean sleep latency ≤8 min and ≥2 Sleep-Onset REM Periods (SOREMPs <15 min); low CSF orexin-A. Rx: Scheduled naps + Modafinil / Armodafinil (1st line daytime wakefulness) + Sodium Oxybate (GHB) or Venlafaxine/SSRIs for Cataplexy |
Sleep Terrors (N3) vs. Nightmare Disorder (REM) vs. REM Sleep Behavior Disorder
Three nocturnal episodes are tested side-by-side on psychiatric and neurology boards: (1) A 6-year-old boy sits bolt upright 90 minutes after falling asleep (first third of the night = Stage N3 slow-wave sleep), screams in terror with dilated pupils, diaphoresis, and tachycardia, cannot be consoled by his parents, returns to sleep, and has zero recall (amnesia) of the event the next morning → Sleep Terror Disorder. (2) A 7-year-old girl awakens crying at 4:30 AM (last third of the night = REM sleep), runs to her parents' room, and describes in vivid detail a monster chasing her → Nightmare Disorder. (3) A 68-year-old man punches his wife in the face at 4:00 AM while dreaming that he is fighting off an intruder and remembers the dream upon waking → REM Sleep Behavior Disorder (early clinical marker of Parkinson disease or Dementia with Lewy Bodies).
Dissociative Disorders: Identity, Amnesia (with Fugue) & Depersonalization/Derealization
Dissociative Disorders represent unconscious disruptions in the normal integration of consciousness, memory, identity, or perception following overwhelming psychological trauma: (1) Dissociative Identity Disorder (formerly multiple personality disorder; strongly linked to severe childhood physical/sexual abuse) features ≥2 distinct personality states accompanied by recurrent gaps in autobiographical memory for everyday events (missing time, finding unfamiliar items in one's closet). (2) Dissociative Amnesia presents with an inability to recall important autobiographical information (usually of a traumatic nature) too extensive to be ordinary forgetfulness; when accompanied by sudden, unexpected purposeful travel away from home with confusion about personal identity, it is specified as with Dissociative Fugue (contrast with Transient Global Amnesia, a neurological disorder in older adults featuring a 4–24 hour loss of anterograde memory with preserved personal identity!). (3) Depersonalization/Derealization Disorder features persistent feelings of detachment from one's body ('watching myself from outside my body') or feeling that the external world is unreal/dreamlike, while reality testing remains completely intact.
Sleep Architecture Changes in Major Depressive Disorder & Aging
Polysomnography in patients with Major Depressive Disorder (MDD) demonstrates characteristic alterations in sleep architecture that are frequently tested on Step 1/Level 1: DECREASED REM sleep latency (entering REM in <45–60 minutes instead of the normal 90 minutes), INCREASED total REM sleep time and REM density (especially in the early part of the night), DECREASED Stage N3 slow-wave delta sleep, and frequent terminal insomnia (early-morning awakenings). Normal physiological aging similarly decreases both Stage N3 slow-wave sleep and total REM sleep while increasing sleep fragmentation.
Eating Disorders (Anorexia vs. Bulimia), Somatic/Factitious/Malingering & Child/Sleep Psychiatry
Anorexia Nervosa is defined by restriction of energy intake leading to a significantly low body weight (BMI <18.5 kg/m2), intense fear of weight gain, and distorted body image (accompanied by lanugo hair, hypothermia, bradycardia, osteoporosis, and GnRH-deficient secondary amenorrhea; refeeding requires close phosphorus/potassium/magnesium monitoring to prevent fatal refeeding syndrome). By contrast, patients with Bulimia Nervosa maintain a normal or elevated body weight (BMI ≥18.5 kg/m2) with recurrent binge eating and compensatory purging (causing dorsal knuckle calluses [Russell's sign], bilateral parotid gland sialadenosis, lingual dental enamel erosion, and hypochloremic hypokalemic metabolic alkalosis; treated with CBT and fluoxetine; bupropion is strictly contraindicated in both anorexia and bulimia due to seizure risk!). Binge-Eating Disorder features recurrent distressful binges without compensatory purging (treated with CBT, SSRIs, or lisdexamfetamine). In somatic/deception differentials: Somatic Symptom Disorder (excessive anxiety over ≥1 persistent physical symptom) and Illness Anxiety Disorder (high health preoccupation with minimal/no somatic symptoms) involve unconscious symptom production and unconscious motivation; Factitious Disorder (Munchausen syndrome) involves conscious, intentional falsification/induction of illness driven by an unconscious psychological motivation to assume the “sick role” (primary gain) without external material reward; and Malingering involves conscious fabrication/exaggeration of symptoms driven by conscious external incentives (secondary gain: financial compensation, avoiding work/jail, or obtaining opioids).
OMM Board Correlate: Autonomic Hyperarousal in Anxiety/Withdrawal, Vagal Regulation & Eating Disorder Viscerosomatics
Sympathetic Hyperarousal in Panic, PTSD & Substance Withdrawal: Acute panic attacks, post-traumatic stress disorder, and alcohol/opioid/benzodiazepine withdrawal states are characterized by profound locus coeruleus noradrenergic discharge and thoracolumbar sympathetic hyperactivity (T1–L2). Specifically, cardiac and pulmonary sympathetic efferents from T1–T5 drive sinus tachycardia, palpitations, hypertension, and hyperventilation, while splanchnic sympathetic fibers (T5–L2) alter gastrointestinal motility and vascular tone. Palpatory exam consistently demonstrates hypertonic paraspinal musculature, warmth, and moisture (sudomotor sympathetic activity) across the upper thoracic spine (T1–T5) and suboccipital triangle.
Vagal Parasympathetic Tone & Electrolytes in Eating Disorders: The Vagus nerve (CN X) exits the skull via the jugular foramen alongside CN IX and CN XI; somatic dysfunction of the occipito-atlantal (OA) joint and occipito-mastoid (OM) suture impairs vagal parasympathetic braking on the sinoatrial node. In patients with Bulimia Nervosa, recurrent self-induced vomiting produces viscerosomatic facilitation at the upper GI foregut segments (T5–T9) alongside parotid gland sialadenosis (innervated parasympathetically by CN IX via the otic ganglion and sympathetically by T1–T3 via the superior cervical ganglion).
OMT Protocol & Contraindications: To downregulate sympathetic hyperarousal in generalized anxiety, PTSD, and insomnia, perform Suboccipital Release (OA decompression), Fourth Ventricle Compression (CV4), Rib Raising (T1–T12), and doming of the respiratory diaphragm. HVLA thrust techniques are CONTRAINDICATED in patients with Anorexia Nervosa due to severe secondary osteoporosis and pathological fracture risk.
- Bupropion (an NDRI antidepressant and smoking-cessation aid) is ABSOLUTELY CONTRAINDICATED in patients with a current or past history of Anorexia Nervosa or Bulimia Nervosa, as well as in patients undergoing abrupt Alcohol or Benzodiazepine withdrawal, because it markedly lowers the seizure threshold and precipitates generalized tonic-clonic seizures!
- In a severely malnourished patient with Anorexia Nervosa (BMI <15–18.5 kg/m2) initiating nutritional rehabilitation, aggressive high-calorie carbohydrate refeeding triggers a massive endogenous INSULIN SURGE that drives extracellular phosphate, potassium, and magnesium into cells (Refeeding Syndrome); hypophosphatemia depletes myocardial and diaphragmatic ATP, causing fatal cardiac arrhythmias, congestive heart failure, rhabdomyolysis, and respiratory failure—always start calories slowly and aggressively monitor/replete serum Phosphate, Potassium, Magnesium, and Thiamine!
- In a patient with decompensated Alcoholic Cirrhosis or acute hepatitis presenting in acute Alcohol Withdrawal, treat with a Benzodiazepine that undergoes direct Phase II glucuronidation WITHOUT Phase I hepatic CYP450 oxidation—memorized via the mnemonic 'LOT': Lorazepam, Oxazepam, or Temazepam (avoid long-acting chlordiazepoxide and diazepam, whose active metabolites accumulate in liver failure and cause prolonged coma!).
- Do NOT diagnose Antisocial Personality Disorder in a patient under age 18; the DSM-5 requires the patient to be at least 18 years old with a documented history of Conduct Disorder (aggression toward people/animals, destruction of property, deceitfulness/theft, serious rule violations) before age 15 (if the patient is <18 years old, the diagnosis is Conduct Disorder!).
- When a patient with a history of Alcohol Use Disorder presents with confusion, ophthalmoplegia (CN VI lateral rectus palsy), and gait ataxia (Wernicke Encephalopathy), ALWAYS administer high-dose intravenous Thiamine (Vitamin B1) BEFORE or concurrently with any intravenous glucose/dextrose infusion; administering glucose before thiamine exhausts remaining B1 stores and precipitates irreversible Korsakoff amnestic-confabulatory syndrome!
- Distinguish REM Sleep Behavior Disorder (loss of normal REM skeletal muscle atonia in older men who violently act out vivid dreams during the last half of the night and immediately recall the dream upon awakening—a prodromal marker of alpha-synucleinopathies such as Parkinson Disease, Lewy Body Dementia, and Multiple System Atrophy; treat with Melatonin or Clonazepam) from N3 Slow-Wave Sleep Terros/Sleepwalking (occurring in children during the first third of the night with complete amnesia for the event).